Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$2.56 - $5.44 $862 - $1,833
-337 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$3.01 - $6.5 $356,079 - $768,943
-118,299 Reduced 99.72%
337 $1,000
Q2 2019

Aug 14, 2019

SELL
$3.3 - $4.58 $229,066 - $317,916
-69,414 Reduced 36.91%
118,636 $442,000
Q1 2019

May 15, 2019

SELL
$3.75 - $4.97 $73,995 - $98,068
-19,732 Reduced 9.5%
188,050 $754,000
Q4 2018

Feb 14, 2019

BUY
$3.29 - $8.94 $488,541 - $1.33 Million
148,493 Added 250.46%
207,782 $762,000
Q3 2018

Dec 21, 2021

BUY
$8.58 - $11.4 $67,378 - $89,524
7,853 Added 15.27%
59,289 $509,000
Q3 2018

Nov 14, 2018

BUY
$8.58 - $11.4 $143,998 - $191,326
16,783 Added 48.43%
51,436 $440,000
Q2 2018

Apr 21, 2020

BUY
$9.42 - $13.73 $77,630 - $113,148
8,241 Added 31.2%
34,653 $381,000
Q2 2018

Aug 14, 2018

SELL
$9.42 - $13.73 $839,849 - $1.22 Million
-89,156 Reduced 77.15%
26,412 $289,000
Q1 2018

Oct 18, 2019

BUY
$7.48 - $11.53 $32,291 - $49,775
4,317 Added 3.88%
115,568 $1.33 Million
Q1 2018

May 15, 2018

BUY
$7.48 - $11.53 $689,603 - $1.06 Million
92,193 Added 483.75%
111,251 $1.28 Million
Q4 2017

Feb 14, 2018

BUY
$9.3 - $16.93 $95,976 - $174,717
10,320 Added 118.1%
19,058 $196,000
Q3 2017

Nov 14, 2017

BUY
$11.3 - $17.23 $98,739 - $150,555
8,738
8,738 $138,000

Others Institutions Holding CRVS

About Corvus Pharmaceuticals, Inc.


  • Ticker CRVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,553,500
  • Market Cap $417M
  • Description
  • Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is Mupadolimab (CPI-006), an anti-CD73 monoclonal antibody, which is in Phase Ib/II clinical trial for non-small cell lung cancer and head and neck cancers. The compan...
More about CRVS
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.